These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 32028670)

  • 61. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PPARs: history and advances.
    Youssef J; Badr MZ
    Methods Mol Biol; 2013; 952():1-6. PubMed ID: 23100221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
    Buroker NE; Barboza J; Huang JY
    FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The molecular mechanisms underlying the proinflammatory actions of thiazolidinediones in human macrophages.
    Hall JM; McDonnell DP
    Mol Endocrinol; 2007 Aug; 21(8):1756-68. PubMed ID: 17488971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice.
    Derosa G; Sahebkar A; Maffioli P
    J Cell Physiol; 2018 Jan; 233(1):153-161. PubMed ID: 28098353
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PPAR agonists modulate human osteoclast formation and activity in vitro.
    Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
    Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha.
    Gani OA; Sylte I
    J Mol Graph Model; 2008 Sep; 27(2):217-24. PubMed ID: 18547851
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The mechanisms of action of PPARs.
    Berger J; Moller DE
    Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.
    Choudhary NS; Kumar N; Duseja A
    J Clin Exp Hepatol; 2019; 9(6):731-739. PubMed ID: 31889755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PPAR ligands: are they potential agents for cardiovascular disorders?
    Balakumar P; Rose M; Singh M
    Pharmacology; 2007; 80(1):1-10. PubMed ID: 17496434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma.
    Kytikova OY; Perelman JM; Novgorodtseva TP; Denisenko YK; Kolosov VP; Antonyuk MV; Gvozdenko TA
    PPAR Res; 2020; 2020():8906968. PubMed ID: 32395125
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
    Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG
    Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
    Gardner OS; Dewar BJ; Graves LM
    Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The roles of PPARs in human diseases.
    Li J; Liu YP
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(7):361-382. PubMed ID: 30036119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
    Schuster M; Zouboulis CC; Ochsendorf F; Müller J; Thaçi D; Bernd A; Kaufmann R; Kippenberger S
    Br J Dermatol; 2011 Jan; 164(1):182-6. PubMed ID: 21091942
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.
    Takano H; Hasegawa H; Zou Y; Komuro I
    Curr Pharm Des; 2004; 10(22):2779-86. PubMed ID: 15320743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.